Introduction
BIPN, MM, neuropathy, Multiple myeloma, axonal damage
NEUROPATHY, HEMATOLOGICAL MALIGNANCIES, PLASMA CELL DISORDER, COMPLICATION, MULTIPLE MYELOMA
Multiple myeloma (MM) is a plasma cell disorder which accounts for 13% of all hematological malignancies [Symptoms may regress after the end of the treatment, but BIPN is a dose limiting complication of BTZ treatment, and in some cases, treatment needs to be discontinued [NfL levels have not yet been reported in patients with BTZ treatment. We investigated whether there are differences in NfL levels in the patients with ongoing BTZ treatment compared to those who have completed their BTZ treatment and to healthy controls, and whether NfL levels would correlate to measures of axonal damage and severity of the neuropathy.